© 2020 MJH Life Sciences™ and Urology Times. All rights reserved.
Kidney Stones
Holmium laser advances help propel progress in BPH, urinary stones
August 05, 2020
Holmium laser lithotripsy with Moses 2.0 is intended to enhance precision and versatility by optimizing laser energy transmission.
Thulium fiber laser shows efficiency advantage in experimental setting
July 29, 2020
Super-pulsed thulium fiber laser (TFL) has greater efficiency than a holmium:YAG laser, even when using the TFL with a smaller core-diameter fiber, according to preclinical findings.
Algorithm may predict health-related quality of life in patients with urolithiasis
July 28, 2020
The machine learning algorithm incorporates readily available clinical information.
Patients undergoing post-URS stent placement more likely to visit ED
July 02, 2020
Study results show wide variation in stent placement following ureteroscopy.
Enzyme lowers urine oxalate levels in patients with enteric hyperoxaluria
June 17, 2020
Study results show a significant reduction in 24-hour urine oxalate in treated patients.
SuperPulsed thulium fiber laser shows several advantages
April 13, 2020
U.S. academic centers using the Soltive SuperPulsed Laser System to treat stones are finding it offers several advantages compared with holmium:YAG laser lithotripsy. But more research comparing the two is needed, according to a presentation at the 2019 World Congress of Endourology in Abu Dhabi, United Arab Emirates.
Pain interference more pronounced following URS
March 11, 2020
Findings from a longitudinal cohort study provide an evidence base for counseling patients about pain and recovery following ureteroscopy for nephrolithiasis.
Most supplements for stones not backed by science
March 06, 2020
Providers should incorporate discussion of dietary supplements into patient counseling, Kevin Koo, MD, MPH, MPhil, advises.
Single-access PCNL feasible for first-line treatment of staghorn calculi
February 28, 2020
Single-access percutaneous nephrolithotomy can clear the vast majority of staghorn stones with minimal morbidity, said Tim Large, MD, at the 2019 World Congress of Endourology and SWL in Abu Dhabi.
Pharmacotherapy reduces recurrence risk for aggressive stone disease
February 28, 2020
Pharmacotherapy for reducing risk of stone recurrence is best reserved for patients with more aggressive disease who are at higher risk for another stone-related event, said Brett A. Johnson, MD, at the 2019 World Congress of Endourology and SWL in Abu Dhabi.